272 related articles for article (PubMed ID: 12438296)
1. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
Inoue S; Egashira K; Ni W; Kitamoto S; Usui M; Otani K; Ishibashi M; Hiasa K; Nishida K; Takeshita A
Circulation; 2002 Nov; 106(21):2700-6. PubMed ID: 12438296
[TBL] [Abstract][Full Text] [Related]
2. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice.
Ni W; Egashira K; Kitamoto S; Kataoka C; Koyanagi M; Inoue S; Imaizumi K; Akiyama C; Nishida KI; Takeshita A
Circulation; 2001 Apr; 103(16):2096-101. PubMed ID: 11319201
[TBL] [Abstract][Full Text] [Related]
3. Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice.
Ni W; Kitamoto S; Ishibashi M; Usui M; Inoue S; Hiasa K; Zhao Q; Nishida K; Takeshita A; Egashira K
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):534-9. PubMed ID: 14739122
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes.
Katsuki S; Matoba T; Nakashiro S; Sato K; Koga J; Nakano K; Nakano Y; Egusa S; Sunagawa K; Egashira K
Circulation; 2014 Feb; 129(8):896-906. PubMed ID: 24305567
[TBL] [Abstract][Full Text] [Related]
5. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice.
Dawson TC; Kuziel WA; Osahar TA; Maeda N
Atherosclerosis; 1999 Mar; 143(1):205-11. PubMed ID: 10208497
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.
Egashira K
Hypertension; 2003 Mar; 41(3 Pt 2):834-41. PubMed ID: 12624005
[TBL] [Abstract][Full Text] [Related]
7. Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention.
Kitamoto S; Egashira K; Takeshita A
J Pharmacol Sci; 2003 Mar; 91(3):192-6. PubMed ID: 12686741
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease.
Kitamoto S; Egashira K
J Atheroscler Thromb; 2002; 9(6):261-5. PubMed ID: 12560586
[TBL] [Abstract][Full Text] [Related]
9. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody.
Lutgens E; Faber B; Schapira K; Evelo CT; van Haaften R; Heeneman S; Cleutjens KB; Bijnens AP; Beckers L; Porter JG; Mackay CR; Rennert P; Bailly V; Jarpe M; Dolinski B; Koteliansky V; de Fougerolles T; Daemen MJ
Circulation; 2005 Jun; 111(25):3443-52. PubMed ID: 15967845
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice.
Dol F; Martin G; Staels B; Mares AM; Cazaubon C; Nisato D; Bidouard JP; Janiak P; Schaeffer P; Herbert JM
J Cardiovasc Pharmacol; 2001 Sep; 38(3):395-405. PubMed ID: 11486244
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.
Veillard NR; Kwak B; Pelli G; Mulhaupt F; James RW; Proudfoot AE; Mach F
Circ Res; 2004 Feb; 94(2):253-61. PubMed ID: 14656931
[TBL] [Abstract][Full Text] [Related]
12. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT
Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988
[TBL] [Abstract][Full Text] [Related]
13. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
14. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
[TBL] [Abstract][Full Text] [Related]
15. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression.
van Royen N; Hoefer I; Böttinger M; Hua J; Grundmann S; Voskuil M; Bode C; Schaper W; Buschmann I; Piek JJ
Circ Res; 2003 Feb; 92(2):218-25. PubMed ID: 12574150
[TBL] [Abstract][Full Text] [Related]
16. Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice.
Mujynya-Ludunge K; Viswambharan H; Driscoll R; Ming XF; von Segesser LK; Kappenberger L; Yang Z; Vassalli G
Basic Res Cardiol; 2005 Mar; 100(2):102-11. PubMed ID: 15578196
[TBL] [Abstract][Full Text] [Related]
17. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.
Boring L; Gosling J; Cleary M; Charo IF
Nature; 1998 Aug; 394(6696):894-7. PubMed ID: 9732872
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory gene therapy for cardiovascular disease.
Matoba T; Egashira K
Curr Gene Ther; 2011 Dec; 11(6):442-6. PubMed ID: 22023473
[TBL] [Abstract][Full Text] [Related]
19. Lesion progression in apoE-deficient mice: implication of chemokines and effect of the AT1 angiotensin II receptor antagonist irbesartan.
Martin G; Dol F; Marés AM; Berezowski V; Staels B; Hum DW; Schaeffer P; Herbert JM
J Cardiovasc Pharmacol; 2004 Feb; 43(2):191-9. PubMed ID: 14716205
[TBL] [Abstract][Full Text] [Related]
20. Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice.
Liu XL; Zhang PF; Ding SF; Wang Y; Zhang M; Zhao YX; Ni M; Zhang Y
PLoS One; 2012; 7(3):e33497. PubMed ID: 22428064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
